Literature DB >> 15318853

Evaluation of red blood cells stored at -80 degrees C in excess of 10 years.

J Lecak1, K Scott, C Young, J Hannon, J P Acker.   

Abstract

BACKGROUND: RBCs frozen in 40 percent (wt/vol) glycerol are currently approved by the FDA and the AABB for storage at -80 degrees C for up to 10 years. STUDY DESIGN AND METHODS: This study examined 20 RBC units that had been cryopreserved in 40 percent (wt/vol) glycerol and stored at -80 degrees C for up to 22 years. Measures of the freeze-thaw-wash (FTW) recovery, ATP, 2,3-DPG, methemoglobin, RBC indices, morphology, and osmotic fragility were made immediately after deglycerolization and after 24 hours of storage at 4 degrees C.
RESULTS: RBCs frozen for longer than 10 years had acceptable mean FTW recovery, normal oxygen transport function, RBC morphology, RBC indices, methemoglobin, and osmotic fragility. Statistical analysis indicated that the in-vitro viability and function of cryopreserved RBCs was not dependent on the length of frozen storage or postthaw storage at 4 degrees C but did correlate with the storage length at 4 degrees C before cryopreservation.
CONCLUSION: The data reported in this study demonstrate that RBCs can be stored at -80 degrees C beyond 10 years with acceptable in-vitro quality and suggest that more defined criteria for the cryopreservation process be adopted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15318853     DOI: 10.1111/j.1537-2995.2004.03271.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  From Development to Implementation: Adjusting the Hematocrit of Deglycerolized Red Cell Concentrates to Meet Regulatory Standards.

Authors:  Tracey Turner; Adele Hansen; Jayme Kurach; Jason P Acker
Journal:  Transfus Med Hemother       Date:  2016-11-04       Impact factor: 3.747

2.  In vitro parameters of cryopreserved leucodepleted and non-leucodepleted red blood cells collected by apheresis or from whole blood and stored in AS-3 for 21 days after thawing.

Authors:  Miloš Bohoněk; Marek Petráš; Ivo Turek; Jaroslava Urbanová; Tomáš Hrádek; Věra Staropražská; Jitka Koštířová; Dana Horčičková; Simona Duchková
Journal:  Blood Transfus       Date:  2013-02-06       Impact factor: 3.443

3.  Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes.

Authors:  Viviana P Ferreira; Michael K Pangburn
Journal:  Blood       Date:  2007-06-06       Impact factor: 22.113

Review 4.  Quality Assessment of Established and Emerging Blood Components for Transfusion.

Authors:  Jason P Acker; Denese C Marks; William P Sheffield
Journal:  J Blood Transfus       Date:  2016-12-14

5.  Red blood cell phenotype fidelity following glycerol cryopreservation optimized for research purposes.

Authors:  Stephen C Rogers; Laura B Dosier; Timothy J McMahon; Hongmei Zhu; David Timm; Hengtao Zhang; Joseph Herbert; Jacqueline Atallah; Gregory M Palmer; Asa Cook; Melanie Ernst; Jaya Prakash; Mark Terng; Parhom Towfighi; Reid Doctor; Ahmed Said; Matthew S Joens; James A J Fitzpatrick; Gabi Hanna; Xue Lin; Julie A Reisz; Travis Nemkov; Angelo D'Alessandro; Allan Doctor
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

6.  The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

Authors:  Viviana P Ferreira; Andrew P Herbert; Claudio Cortés; Kristi A McKee; Bärbel S Blaum; Stefan T Esswein; Dusan Uhrín; Paul N Barlow; Michael K Pangburn; David Kavanagh
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.